| Literature DB >> 29249690 |
Tianyi Wang1, Johannes Francois Fahrmann2, Heehyoung Lee3, Yi-Jia Li4, Satyendra C Tripathi2, Chanyu Yue3, Chunyan Zhang4, Veronica Lifshitz4, Jieun Song4, Yuan Yuan5, George Somlo5, Rahul Jandial6, David Ann7, Samir Hanash2, Richard Jove8, Hua Yu9.
Abstract
Cancer stem cells (CSCs) are critical for cancer progression and chemoresistance. How lipid metabolism regulates CSCs and chemoresistance remains elusive. Here, we demonstrate that JAK/STAT3 regulates lipid metabolism, which promotes breast CSCs (BCSCs) and cancer chemoresistance. Inhibiting JAK/STAT3 blocks BCSC self-renewal and expression of diverse lipid metabolic genes, including carnitine palmitoyltransferase 1B (CPT1B), which encodes the critical enzyme for fatty acid β-oxidation (FAO). Moreover, mammary-adipocyte-derived leptin upregulates STAT3-induced CPT1B expression and FAO activity in BCSCs. Human breast-cancer-derived data suggest that the STAT3-CPT1B-FAO pathway promotes cancer cell stemness and chemoresistance. Blocking FAO and/or leptin re-sensitizes them to chemotherapy and inhibits BCSCs in mouse breast tumors in vivo. We identify a critical pathway for BCSC maintenance and breast cancer chemoresistance.Entities:
Keywords: JAK/STAT3; breast cancer stem cell; chemoresistance; fatty acid β-oxidation; leptin
Mesh:
Substances:
Year: 2017 PMID: 29249690 PMCID: PMC5777338 DOI: 10.1016/j.cmet.2017.11.001
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287